Guidance: COVID-19: guidance on protecting people defined on medical grounds as extremely vulnerable
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Information for protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19).
Recording and reporting requirements for laboratories in accordance with the primary high risk human papillomavirus (hrHPV) screening pathway.
This document explains procedures for the reporting of cervical biopsies in the NHS cervical screening programme.
Guidance on managing people who wish to attend an alternative screening centre to the one the programme invites them to attend.
Guidelines for commissioners, screening providers and programme managers for NHS cervical screening.
Guidelines to support local action on health inequalities.
This document provides a summary of activity during the financial year 2020 to 2021 in relation to work governed by this group.
Find the appropriate standard and its current status.
Monthly updates on new or emerging infectious disease events that could affect UK public health.
Screening standards for the NHS Fetal Anomaly Screening Programme (FASP).